Although PPM1D mutations have been identified in patients with CH, particularly in patients with prior chemoradiotherapy exposure, GWAS of patients with CH and/or myeloid malignancies did not identify underlying germline PPM1D mutations [1, 2]. This evidence concerns the gene PPM1D and cyclic hematopoiesis.